Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CDK9-IN-12

🥰Excellent
Catalog No. T39354Cas No. 1942843-54-0

CDK9-IN-12 is a highly selective CDK9 inhibitor, which is commonly used in leukemia research to regulate oncogene expression, inhibit oncogenic proliferation, and induce apoptosis by targeting CDK9-dependent transcription processes.

CDK9-IN-12

CDK9-IN-12

🥰Excellent
Purity: 98.93%
Catalog No. T39354Cas No. 1942843-54-0
CDK9-IN-12 is a highly selective CDK9 inhibitor, which is commonly used in leukemia research to regulate oncogene expression, inhibit oncogenic proliferation, and induce apoptosis by targeting CDK9-dependent transcription processes.
Pack SizePriceAvailabilityQuantity
1 mg$397 In Stock
5 mg$970 In Stock
10 mg$1,290 In Stock
25 mg$1,950 In Stock
50 mg$2,620 In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:98.93%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
CDK9-IN-12 is a highly selective CDK9 inhibitor, which is commonly used in leukemia research to regulate oncogene expression, inhibit oncogenic proliferation, and induce apoptosis by targeting CDK9-dependent transcription processes.
Targets&IC50
CDK9-CyclinT1:5.41 nM
In vitro
CDK9-IN-12 has an inhibitory effect on the following cells: Mino, Z-138, JeKo-1, Raji, OCI-Ly-10, TMD8, MM.1S, RPMI-8226, Kasumi-1, HL-60, CCRF-CEM, MV-4-11 cells with IC50 values ​​of 8.4, 46, 46, 37, 3.2, 46, 1.5, 5.4, 21, 44, 2.1, 1.6 nM, respectively. [1]
In vivo
Methods: CDK9-IN-12 (7.5 mg/kg, 0.5% CMC-Na, gavage, 21 days) was used to treat MV-4-11 cell tumor xenograft model mice. First, PK experiments were performed in mice. Second, the diameter of the transplanted tumor and the weight of the mice were measured twice a week to evaluate the in vivo anticancer effect.
Results: CDK9-IN-12 has a long half-life (t1/2 = 8.02 h) and acceptable bioavailability (F = 33.7%). In addition, CDK9-IN-12 can significantly inhibit tumor progression, with a T/C value of 27.80%. [1]
Chemical Properties
Molecular Weight378.86
FormulaC21H19ClN4O
Cas No.1942843-54-0
SmilesClC1=C(C=2C=C3C(=CC2)NN=C3C)C=C(N[C@@H](CO)C4=CC=CC=C4)C=N1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (211.16 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6395 mL13.1975 mL26.3950 mL131.9749 mL
5 mM0.5279 mL2.6395 mL5.2790 mL26.3950 mL
10 mM0.2639 mL1.3197 mL2.6395 mL13.1975 mL
20 mM0.1320 mL0.6599 mL1.3197 mL6.5987 mL
50 mM0.0528 mL0.2639 mL0.5279 mL2.6395 mL
100 mM0.0264 mL0.1320 mL0.2639 mL1.3197 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CDK9-IN-12 | purchase CDK9-IN-12 | CDK9-IN-12 cost | order CDK9-IN-12 | CDK9-IN-12 chemical structure | CDK9-IN-12 in vivo | CDK9-IN-12 in vitro | CDK9-IN-12 formula | CDK9-IN-12 molecular weight